Crosland Kimberly A, Zarcone Jennifer R, Lindauer Steven E, Valdovinos Maria G, Zarcone Troy J, Hellings Jessica A, Schroeder Stephen R
University of Kansas, Lawrence, Kansas 66045-7555, USA.
J Autism Dev Disord. 2003 Jun;33(3):271-9. doi: 10.1023/a:1024402500425.
The atypical antipsychotic medication risperidone was evaluated using a double-blind, placebo-controlled design in the treatment of destructive behavior in two individuals with autism. Pre-medication functional analyses indicated that destructive behavior was maintained by escape from demands, attention, or access to tangible items. For both individuals, destructive behavior during the demand condition was significantly reduced during the medication phases, whereas destructive behavior continued to occur to obtain tangible items (Reggie) and attention (Sean). In addition, there appeared to be a differential effect of the medication on self-injurious behavior (SIB) versus aggression for Sean. Results of the study demonstrate how functional analysis may provide information on those conditions and behaviors that are most likely to be affected by a specific medication.
